Skip to main content
. 2019 Mar 25;14(3):e0213614. doi: 10.1371/journal.pone.0213614

Fig 1.

Fig 1

(a) Incidence rates and hazard ratios for patients with DOAC vs warfarin (b) incidence rates and hazard ratios for patients with DOAC vs DOACs. CI: confidence interval; GI: gastrointestinal; ICH: intracranial hemorrhage; MACE: major adverse cardiovascular event; SE: systemic embolism.